Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope

Virology

Volumn 223, Issue 2, 1996, Pages 406-408

  Sabatier, Jean Marc ^a   Mabrouk, Kamel ^a,c   Moulard, Maxime ^b   Rochat, Hervé ^a   Van Rietschoten, Jurphaas ^a   Fenouillet, Emmanuel ^a  

^a CNRS   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HYBRID PROTEIN; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SYNCYTIUM; VIRUS ENVELOPE; VIRUS REPLICATION;

EID: 0030587423     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0496     Document Type: Article

References (17)

1. 1. Moore, J. P., Jameson, B. A., Weiss, R. A., and Sattentau, Q. J., "Viral Fusion Mechanism" (J. Bentz, Ed.), pp. 234-289. CRC Press, Boca Raton, FL, 1992.
2. 2. Yahi, N., Fantini, J., Mabrouk, K., Tamalet, C., De Micco, P., Rochat, H., Van Rietschoten, J., and Sabatier, J. M., J. Virol. 68, 5714-5720 (1994).
3. 3. Benjouad, A., Chapuis, F., Fenouillet, E., and Gluckman, J. C., Virology 206, 457-465 (1995).
4. 4. Yahi, N., Fantini, J., Baghdighian, S., Mabrouk, K., Tamalet, C., Rochat, H., Van Rietschoten, J., and Sabatier, J. M., Proc. Natl. Acad. Sci. USA 92, 4867-4871 (1995).
5. 5. Lu, M., Blacklow, S., and Kim, P. S., Nat. Struct. Biol. 2, 1075-1082 (1995).
6. 6. Slepushkin, V., Kornilaeva, G., Andreev, S., Sidorova, M., Petrukina, A., Matsedvitch, G., Raduk, S., Grigoriev, V., Marakova, T., Lukashov, V., and Karamov, E., Virology 194, 294-301 (1993).
7. 7. Neurath, A., Strick, N., and Jang, S., Virology 188, 1-13 (1992).
8. 8. Sagara, Y., Inoue, Y., Shiraki, H., Jnno, A., Hoshino, H., and Maeda, Y., J. Virol. 70, 1564-1569 (1996).
9. 9. Neurath, A., Lin, K., Strick, N., and Jang, S., AIDS Res. Hum. Retroviruses 11, 189-190 (1995).
10. 10. Bernstein, H., Tucker, S., Kar, S., McPherson, S., McPherson, D., Dubay, J., Compans, R., and Hunter, E., J. Virol. 69, 2745-2750 (1995).
11. 11. Chen, C., Matthews, T., McDanal, C., Bolognesi, D., and Greenberg, M., J. Virol. 69, 3771-3777 (1995).
12. 12. Cao, J., Bergeron, L., Helseth, E., Thali, M., Repke, H., and Sodroski, J., J. Virol. 67, 2747-2755 (1993).
13. 13. Fenouillet, E., Miquelis, R., and Drillien, R., Virology 218, 224-231 (1996).
14. 14. Moore, P. S., Jones, C. J., Mahmood, N., Evans, I. G., Coff, M., Cooper, R., and Hay, H. J., Biochem. J. 307, 129-134.
15. 15. Clapham, P. R., McKnight, A., and Weiss, R. A., J. Virol. 66, 3531-3537 (1992).
16. 16. Conley, A. J., Kessler, J. A., Boots, L. J., Tung, J. S., Arnold, B. A., Keller, P. M., Shaw, A. R., and Emini, E. A., Proc. Natl. Acad. Sci. USA 91, 3348-3352 (1994).
17. 17. Jang, S., Lin, K., Strick, N., and Neurath, A. R., Biochem. Biophys. Res. Commun. 195, 533-538 (1993).